Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer
Clinical trial NCT03009058 · TERMINATED
Trial details
- NCT number
- NCT03009058
- Sponsor
- Immodulon Therapeutics Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2017-08-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.